查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1847196

印度牙科移植骨替代物市场：市场规模、份额和趋势分析（2025-2031）

Dental Bone Graft Substitutes Market Size, Share & Trends Analysis | India | 2025-2031 | Includes: Barrier Membranes, Antimicrobial Periodontal Treatment, and 2 more
出版日期: | 出版商: iData Research Inc. | 英文 80 Pages | 商品交期: 最快1-2个工作天内

价格
如有价格方面的疑问请按下「询问」键来信查询

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年印度牙科移植骨替代物(DBGS) 和其他生医材料市场规模超过 5,600 万美元，预计到 2031 年将达到近 1.51 亿美元。

本报告涵盖牙科移植骨替代物、牙科屏障膜、局部抗菌牙周治疗以及牙科软组织伤口护理—统称为牙科生医材料市场。该报告对销售额、平均售价 (ASP)、市场规模、成长率和企业市场占有率进行了全面分析，并提供了截至 2031 年的预测数据和截至 2021 年的实际数据。

印度市场是全球成长最快的市场之一，这主要得益于人工植牙普及率的提高、临床医生培训的广泛开展以及消费者对再生医学治疗意识的增强。牙科旅游的蓬勃发展和对私人诊所投资的增加进一步推动了对先进生医材料的需求，尤其是合成和异种移植的DBGS产品以及牙科屏障膜。

市场概览

受人口和经济发展趋势的推动，印度牙科生医材料市场正处于强劲扩张阶段。中阶的壮大、人们审美意识的提升以及植入治疗的普及，都促进了再生牙科产品的市场应用。

历史上，由于成本优势和供应便利，印度生物活性骨移植（DBGS）市场一直以合成材料为主。然而，近年来，异质骨移植市场稳步成长，凭藉更完善的灭菌技术、更佳的临床疗效以及来自知名国际製造商的品牌推广，赢得了临床医生的信赖。

印度正在发生的一项重要变化是牙科屏障膜的接受度和应用率不断提高。虽然这些产品过去不如牙科生物膜材料普及，但现在它们已被公认为引导骨再生（GBR）和引导组织再生（GTR）手术的重要组成部分。特别是可吸收胶原蛋白膜，在教育推广和企业主导的研讨会的推动下，其应用率正在迅速提高。

印度的市场结构由盖斯特利希（Geistlich）、士卓曼集团（Straumann Group）和哈尔玛（Halma）等全球领导企业，以及本土经销商和区域性参与企业组成。印度的牙科基础设施和采购管道较为分散，因此建立本地伙伴关係和分销管道至关重要。

总体而言，植入数量的增加、患者意识的提高以及国内外供应商的大力行销正在推动成长，使印度成为亚太地区最有前途的牙科生医材料市场之一。

市场驱动因素

人工植牙治疗的发展

齿槽骨移植是植入治疗中必不可少的环节，它支持植入植入前后的骨修復。随着印度私人牙科领域植入的快速普及，齿槽骨移植材料的需求也持续成长。

虽然并非所有植入都​​需要植骨，但相当一部分病例，尤其是在上颚和下颚后牙区，透过植骨可以确保长期稳定性。植入植入与植骨之间的这种结构性联繫，决定了随着植入手术的增长，对骨移植的需求也会增加。

提高消费者意识

消费者对人工植牙和再生手术的认知度正在显着提高，患者透过数位管道和植入及生医材料製造商赞助的教育宣传活动，对他们的治疗选择有了更深入的了解。

不断扩大的知识库提高了临床接受度和消费者信心，促进了 DBGS 和屏障膜产品的稳定应用。

捆绑销售和投资组合扩展

领先的牙科公司正利用产品捆绑销售策略，交叉销售再生生物材料、膜和植入系统。包括盖斯特利希（Geistlich）、士卓曼（Straumann）和哈尔玛（Halma）在内的许多全球公司，在植入产品之外还提供再生材料，鼓励临床医生从单一供应商处采购配套产品。

此类伙伴关係简化了牙科诊所的物流，并提高了操作流程的一致性。例如，Geistlich 的 Bio-Gide® 薄膜通常与 Bio-Oss®异质骨移植搭配使用，而 Straumann 则将其 Bone Ceramic® 材料作为植入再生方案的一部分进行推广。

此次将植入和生医材料产品组合整合起来，将增强销售综效，并提高整体市场渗透率。

私人医疗保健和牙科旅游的发展

印度私人医疗保健行业的扩张和蓬勃发展的牙科旅游业正推动对先进牙科技术的投资不断增加。服务于国际患者和国内富裕患者的诊所越来越多地采用高端牙科生物材料和膜材料，以确保可预测的美学效果。

具有竞争力的价格和日益增长的国际声誉使印度成为植入治疗的首选目的地，进一步推动了对再生材料的需求。

市场限制

改善口腔卫生

政府和非政府组织主导的口腔卫生宣传活动正在提高印度各地民众对预防牙科的认识，这从公共卫生角度来看是有益的，但从长远来看，可能会抑制对修復和再生手术的需求。

然而，儘管预防保健有所改善，但城市人口对美观的期望不断提高，对牙齿修復的需求也持续增长，导致牙齿修復手术数量持续增加。

缺乏保险保障

与许多新兴市场不同，印度的公共医疗保险不涵盖牙科生医材料手术，患者必须自费支付植体和膜植入的全部费用。

这种经济负担限制了高成本异质骨移植和同种移植的应用，尤其是在主要城市中心以外的地区。因此，价格敏感的合成膜移植仍然是大多数私人诊所的首选。

对疾病传播的担忧

文化和职业因素对人类和动物性疾病传播的担忧持续影响临床医生的偏好，儘管无菌和安全标准已经进步，但人们对风险的认知仍然存在，尤其是在较小的城市。

感染疾病和组织获取问题的报告会迅速降低临床医生的信心，并可能迫使暂时转向合成或自体移植。

基础设施和培训方面的差距

儘管牙科教育取得了显着进步，但印度各地获得再生医学培训和专用设备的机会仍然不均衡。小型诊所可能缺乏进行高阶移植和膜移植手术所需的工具和信心。

这种差异导致了区域市场失衡，孟买、德里和班加罗尔等大城市占了DBGS消费的大部分。

目标市场和数据范围

  • 量化指标：市场规模、市占率、预测、成长率、销售量、平均售价。
  • 定性内容：成长趋势、市场限制、主要竞争对手的竞争分析和 SWOT 分析、併购、公司简介、产品系列、颠覆性技术、影响手术需求的疾病概述。
  • 时段：基准年为 2024 年，预测至 2031 年，历史资料为 2021 年至 2023 年。
  • 资料来源：对行业领导者的直接访谈、政府和监管资料、医院和私人诊所资讯来源、进出口资料库、iData Research 的专有医疗技术资料集。
  • 方法说明：市场收入以单位 x 平均售价 (ASP) 为模型，并透过手术和临床利用数据检验。

分析的医疗机构包括私人牙科诊所、综合医院和学术机构。

目标市场及区隔

牙科移植骨替代物（DBGS）

  • 依类型：矿化同种异体移植、脱矿骨基质（DBM）同种异体移植、异质骨移植和合成移植。

牙科屏障膜

  • 依类型：可吸收型、不可吸收型
  • 依材料分类：同种异体移植、异质骨移植、复合材料。

抗菌牙周治疗

含有局部应用的抗菌剂，用于控制感染和促进牙周疾病的癒合。

牙科软组织伤口护理

  • 按类型：塞子、胶带、泡棉。

仅对单元层面的细分市场进行分析。

每个子类别包括市场价值、销售、平均售价和预期成长率。

竞争分析

2024年，印度牙科生医材料市场由盖斯特利希製药公司(Geistlich Pharma AG)主导。该公司旗舰产品Bio-Oss®异种移植材料被公认为骨再生领域的黄金标准。盖斯特利希的配套产品Bio-Gide®膜产品线进一步巩固了其在可吸收膜领域的领先地位。

儘管经济压力导致一些临床医生寻求成本更低的替代方案，但盖斯特利希凭藉其持续的临床教育计画和在学术机构中的良好声誉，仍然保持着领先地位。

Halma plc凭藉在合成DBGS领域的卓越表现排名第二。透过其专业子公司，Halma plc有效地推广了价格亲民的合成植体材料，满足了印度注重性价比的市场需求。自2018年与ZimVie Dental签订独家经销协议以来，Halma plc进一步拓展了其在植入专家中的影响力，并提升了其产品的信誉度。

士卓曼集团对合成材料和双相材料的策略重点在2024年占据了显着的市场份额。该公司研发的骨陶瓷®（Bone Ceramic®）－一种由羟基磷灰石（HA）和β-磷酸三钙（B-TCP）组成的复合材料－被推广为士卓曼植入系统的再生补充资料。这种整合使临床医生能够利用相容的再生解决方案简化植入设计流程。

士卓曼的 Neodent® 品牌定位为经济实惠的植入系列，同时提高了公司 DBGS 和膜产品的知名度和交叉销售机会。

整体而言，竞争格局瞬息万变，全球领导企业与本地经销商和新兴的印度製造商竞争。高成长环境鼓励伙伴关係、扩大分销管道和实现产品组合多元化。

技术与实务趋势

  • 转向使用屏障膜：牙科膜曾经被认为是可有可无的，但现在被认为是获得可预测的 GBR 结果的必要条件。
  • 可吸收膜的兴起：胶原蛋白基可吸收膜因其使用方便、患者舒适，正成为市场上主流的新产品。
  • 优化合成材料：製造商不断改进合成移植物孔隙率、吸收率和生物相容性，以模拟天然骨再生。
  • 综合培训：人工植牙课程现在包含植骨和膜模组，确保从业人员在其职业生涯早期就能学习循证再生通讯协定。
  • 捆绑式产品：植入製造商正日益整合其再生产品组合，以提供包含移植片和膜的承包手术套件。
  • 都市区采用集中度：高端再生製程集中在一线城市，而对价格敏感的合成材料正在二、三线市场扩张。

综合来看，这些趋势显示印度的牙科生医材料市场正从成本主导转变为临床主导型。

地区

本期聚焦印度。

它包含 96 页详细的说明、表格和图表。

为什么要选择这份报告？

印度牙科生医材料市场成长最快的机会有哪些？

合成材料和异种移植材料在临床应用上如何竞争？

在印度，屏障膜产品是植入主导市场中成长最快的市场。

定价、教育和销售合作关係如何影响采用率。

文化因素与公共报销缺口如何影响产品需求？

哪些公司在市占率方面处于领先地位？到 2031 年，它们将如何定位自身以实现成长？

供应商如何将植入和生医材料捆绑销售，以最大限度地扩大市场份额？

哪些风险可能会限制未来的成长？企业如何透过临床培训和沟通来降低这些风险？

iData Research 的《印度牙科骨移植片和其他生医材料市场报告》透过基于程式的建模、定价数据和竞争份额分析来回答这些问题。

在世界成长最快的牙科市场之一中，量化需求，规划新产品发布，并对标您的策略。

目录

图表清单

图表列表

调查方法

全球关税的影响

印度牙科移植骨替代物及其他生医材料市场

  • 执行摘要
    • 印度牙科移植骨替代物及其他生医材料市场概览
    • 竞争分析
    • 市场趋势
    • 流程分段
    • 市场区隔
  • 介绍
    • 牙科骨移植替代物
    • 牙科屏障膜
    • 局部抗菌牙周治疗
  • 手术次数
    • 齿槽骨移植手术
  • 计数分析
    • 按手术类型分類的牙科骨移植替代材料销售情况
    • 牙科屏障膜单元（按尺寸）
  • 外汇
  • 市场概览
  • 市场分析与预测
    • 牙科骨移植替代物市场
    • 牙科屏障膜市场
    • 抗菌牙周病治疗市场
    • 牙科软组织创伤护理市场
  • 驾驶员和约束装置
  • 竞争市占率分析
    • 牙科骨移植替代材料市场竞争格局分析
    • 牙科屏障膜市场竞争格局及市场占有率分析
    • 抗菌牙周治疗市场竞争市占率分析

简称

Product Code: iDATA_INDBGS25_MS

The Indian dental bone graft substitute (DBGS) and other biomaterials market was valued at over $56 million in 2024. It is projected to grow, reaching nearly $151 million by 2031.

This report covers dental bone graft substitutes, dental barrier membranes, local antimicrobial periodontal treatments, and dental soft tissue wound care-collectively referred to as the dental biomaterials market. It provides comprehensive analysis across unit sales, average selling prices (ASPs), market size, growth rates, and company shares, and includes forecasts through 2031 and historical data back to 2021.

India's market is among the fastest growing globally due to expanding dental implant adoption, broader clinician training, and rising consumer awareness of regenerative procedures. The surge in dental tourism and private clinic investment is further boosting demand for advanced biomaterials, particularly synthetic and xenograft DBGS products and dental barrier membranes.

Market Overview

The Indian dental biomaterials market is in a strong expansion phase, supported by demographic and economic trends. A growing middle class, increased aesthetic awareness, and greater access to dental implant procedures are driving the uptake of regenerative dental products.

Historically, India's DBGS market has been dominated by synthetic materials due to cost advantages and availability. However, the xenograft segment has expanded steadily in recent years, gaining clinician confidence through improved sterilization, clinical outcomes, and branding from established global manufacturers.

An important shift underway in India is the rising acceptance and adoption of dental barrier membranes. While these products have historically lagged in penetration compared to DBGS materials, they are now being recognized as an essential component of guided bone regeneration (GBR) and guided tissue regeneration (GTR) procedures. Educational initiatives and company-driven workshops are accelerating the uptake of these materials, particularly resorbable collagen membranes.

The market's structure reflects a mix of global leaders such as Geistlich, Straumann Group, and Halma, alongside domestic distributors and regional players. Local partnerships and distribution alliances are critical due to India's fragmented dental infrastructure and procurement channels.

Overall, growth is being driven by a combination of rising implant procedure volumes, growing patient awareness, and strong marketing by international and domestic suppliers, positioning India as one of the most promising dental biomaterials markets in the Asia-Pacific region.

Market Drivers

Growth of Dental Implant Procedures

Dental bone grafting is integral to implantology, supporting bone volume restoration before or during implant placement. As implant adoption accelerates in India's private dental sector, the demand for DBGS materials continues to expand.

While not every implant requires a bone graft, a significant proportion of cases-especially in posterior maxilla and mandible regions-benefit from grafting to ensure long-term stability. This structural link between implant placement and bone grafting ensures that DBGS demand rises alongside implant procedure growth.

Growing Consumer Awareness

Public awareness of dental implantology and regenerative procedures has increased markedly. Patients are becoming more informed about treatment options through digital channels and educational campaigns sponsored by implant and biomaterial manufacturers.

This expanding knowledge base has elevated both clinical acceptance and consumer trust, driving steady procedural adoption of DBGS and barrier membrane products.

Bundling and Portfolio Expansion

Leading dental companies are leveraging product bundling strategies to cross-sell DBGS materials, membranes, and implant systems. Many global firms-including Geistlich, Straumann, and Halma-offer regenerative materials alongside implants, encouraging clinicians to source complementary products from a single supplier.

These partnerships simplify logistics for dental clinics and enhance procedural consistency. For example, Geistlich's Bio-Gide(R) membranes are commonly used with its Bio-Oss(R) xenografts, while Straumann promotes its Bone Ceramic(R) material as part of its implant regeneration package.

Such integration of implants and biomaterials portfolios enhances sales synergy and drives higher overall market penetration.

Private Healthcare Growth and Dental Tourism

India's private healthcare expansion and booming dental tourism sector have amplified investment in advanced dental technologies. Clinics catering to international and affluent domestic patients increasingly adopt premium DBGS and membrane materials to ensure predictable aesthetic outcomes.

With competitive pricing and growing international reputation, India has become a favored destination for implant procedures, further bolstering demand for regenerative materials.

Market Limiters

Improvements in Oral Health

Preventive dental awareness is improving across India due to government and NGO-led oral hygiene campaigns. While this is beneficial from a public health standpoint, it may slow long-term demand for restorative and regenerative procedures.

Nevertheless, rising aesthetic expectations and tooth replacement demand among urban populations continue to sustain procedural volume growth despite better preventive care.

Lack of Insurance Coverage

Unlike in many developed markets, dental biomaterial procedures in India are not covered by public health insurance. Patients must pay the entire cost of grafting and membrane placement out of pocket.

This financial burden limits the adoption of high-cost xenograft and allograft products, particularly outside major metropolitan centers. As a result, price-sensitive synthetic grafts remain the dominant choice for most private practitioners.

Concerns About Disease Transmission

Cultural and professional apprehension about disease transmission from human or animal sources continues to influence clinician preferences. Although sterilization and safety standards have advanced, the perception of risk persists, particularly in smaller cities.

Any reports of infection or issues in tissue sourcing can quickly reduce clinician confidence, leading to temporary shifts back to synthetic or autogenous grafts.

Infrastructure and Training Gaps

Despite major progress in dental education, access to regenerative training and specialized equipment remains uneven across India. Smaller clinics may lack the tools and confidence required for advanced grafting or membrane procedures.

This disparity reinforces regional market imbalances, with major cities like Mumbai, Delhi, and Bengaluru accounting for the majority of DBGS consumption.

Market Coverage and Data Scope

  • Quantitative coverage: Market size, market shares, forecasts, growth rates, units sold, and average selling prices.
  • Qualitative coverage: Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, and disease overviews that influence procedural demand.
  • Time frame: Base year 2024, forecasts to 2031, and historical data from 2021 to 2023.
  • Data sources: Primary interviews with industry leaders, government and regulatory data, hospital and private clinic sources, import/export databases, and iData Research's proprietary MedTech dataset.
  • Method note: Market revenue is modeled from units X ASP, validated with procedural and clinical utilization data.

Care settings analyzed include private dental clinics, multispecialty hospitals, and academic institutions.

Markets Covered and Segmentation

Dental Bone Graft Substitutes (DBGS)

  • By type: Mineralized allografts, demineralized bone matrix (DBM) allografts, xenografts, synthetics.

Dental Barrier Membranes

  • By type: Resorbable, non-resorbable.
  • By material: Allograft, xenograft, synthetic.

Antimicrobial Periodontal Treatment

Includes locally applied antimicrobial agents used to control infection and promote periodontal healing.

Dental Soft Tissue Wound Care

  • By type: Plug, tape, foam.

Segment analyzed at the unit level only.

Each subcategory includes market values, units sold, ASPs, and forecast growth rates.

Competitive Analysis

Geistlich Pharma AG led the Indian dental biomaterials market in 2024. Its flagship xenograft product, Bio-Oss(R), is widely regarded as the gold standard for bone regeneration. Geistlich's complementary Bio-Gide(R) membrane line further reinforces its leadership by dominating the resorbable membrane segment.

Despite broader economic pressures that encouraged some clinicians to explore lower-cost alternatives, Geistlich retained its top position through consistent clinical education programs and a strong reputation among academic institutions.

Halma plc ranked second, driven by its success in the synthetic DBGS segment. Through its specialized subsidiaries, Halma has effectively promoted affordable synthetic graft materials that appeal to India's value-oriented market. Its exclusive distribution agreement with ZimVie Dental since 2018 strengthened its reach and product credibility among implant specialists.

Straumann Group held a notable market share in 2024, with a strategic focus on synthetic and biphasic materials. Its Bone Ceramic(R)-a combination of hydroxyapatite (HA) and beta-tricalcium phosphate (B-TCP)-was promoted as a regenerative complement to Straumann's implant systems. This integration allowed clinicians to streamline implant planning with compatible regenerative solutions.

Straumann's Neodent(R) brand, positioned as a cost-effective implant line, also enhanced visibility and cross-selling opportunities for the company's DBGS and membrane products.

Overall, the competitive environment is dynamic, with global leaders competing alongside local distributors and emerging Indian manufacturers. The high-growth environment encourages partnerships, distribution expansion, and portfolio diversification.

Technology and Practice Trends

  • Shift toward barrier membrane use: Dental membranes, once considered optional, are now viewed as essential for predictable GBR outcomes.
  • Resorbable membranes gaining traction: Collagen-based resorbable membranes dominate new product introductions due to handling simplicity and patient comfort.
  • Synthetic material optimization: Manufacturers continue improving porosity, resorption rates, and biocompatibility of synthetic grafts to emulate natural bone regeneration.
  • Training integration: Dental implant courses now incorporate grafting and membrane modules, ensuring practitioners learn evidence-based regenerative protocols early in their careers.
  • Bundled offerings: Implant manufacturers increasingly integrate regenerative portfolios, offering turnkey surgical kits that include grafts and membranes.
  • Urban concentration of adoption: High-end regenerative procedures are concentrated in Tier 1 cities, while price-sensitive synthetic materials are expanding in Tier 2 and 3 markets.

Collectively, these trends underline India's transition from a cost-driven to a clinically driven dental biomaterials market.

Geography

This edition focuses on India.

96 pages of in-depth narrative, tables, and charts.

Why This Report

Where is the fastest-growing opportunity within India's dental biomaterials market?

How are synthetic and xenograft materials competing in clinical adoption?

Which barrier membrane products are expanding most rapidly in India's implant-driven market?

What is the impact of pricing, education, and distribution partnerships on adoption rates?

How do cultural factors and public reimbursement gaps shape product demand?

Which companies are leading in market share, and how are they positioning for growth through 2031?

How can suppliers bundle implants and biomaterials to maximize market presence?

What risks may limit future growth, and how can companies mitigate them through clinical training and communication?

The India Dental Bone Graft Substitute and Other Biomaterials Market Report from iData Research answers these questions with procedure-based modeling, pricing data, and competitive share analysis.

Use it to quantify demand, plan new product entries, and benchmark strategies in one of the world's fastest-growing dental markets.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

India Dental Bone Graft Substitute and Other Biomaterials Market

  • 7.1 Executive Summary
    • 7.1.1 India Dental Bone Graft Substitute and Other Biomaterials Market Overview
    • 7.1.2 Competitive Analysis
    • 7.1.3 Market Trends
    • 7.1.4 Procedure Segmentation
    • 7.1.5 Market Segmentation
  • 7.2 Introduction
    • 7.2.1 Dental Bone Graft Substitutes
      • 7.2.1.1 Autografts
      • 7.2.1.2 Allografts
      • 7.2.1.2.1 Mineralized Allografts
      • 7.2.1.2.2 Demineralized Bone Matrix
      • 7.2.1.3 Xenografts
      • 7.2.1.4 Synthetics
    • 7.2.2 Dental Barrier Membranes
    • 7.2.3 Local Antimicrobial Periodontal Treatment
  • 7.3 Procedure Numbers
    • 7.3.1 Dental Bone Grafting Procedures
  • 7.4 Unit Analysis
    • 7.4.1 Dental Bone Graft Substitute Units Sold by Procedure Type
    • 7.4.2 Dental Barrier Membrane Units Sold by Size
      • 7.4.2.1 Resorbable Dental Barrier Membrane Units Sold by Size
      • 7.4.2.2 Non-Resorbable Dental Barrier Membrane Units Sold by Size
  • 7.5 Currency Exchange Rate
  • 7.6 Market Overview
  • 7.7 Market Analysis and Forecast
    • 7.7.1 Dental Bone Graft Substitute Market
      • 7.7.1.1 Allograft Market
      • 7.7.1.1.1 Mineralized Allograft Market
      • 7.7.1.1.2 Demineralized Bone Matrix Allograft Market
      • 7.7.1.2 Xenograft Market
      • 7.7.1.3 Synthetic Market
    • 7.7.2 Dental Barrier Membrane Market
      • 7.7.2.1 Dental Barrier Membrane Market by Segment
      • 7.7.2.1.1 Allograft Dental Barrier Membrane Market
      • 7.7.2.1.2 Xenograft Dental Barrier Membrane Market
      • 7.7.2.1.3 Synthetic Dental Barrier Membrane Market
      • 7.7.2.2 Dental Barrier Membrane Market by Material
      • 7.7.2.2.1 Resorbable Dental Barrier Membrane Market
      • 7.7.2.2.2 Non-Resorbable Dental Barrier Membrane Market
    • 7.7.3 Antimicrobial Periodontal Treatment Market
    • 7.7.4 Dental Soft Tissue Wound Care Market
      • 7.7.4.1 Dental Wound Care Plugs Market
      • 7.7.4.2 Dental Wound Care Tape Market
      • 7.7.4.3 Dental Wound Care Foam Market
  • 7.8 Drivers and Limiters
    • 7.8.1 Market Drivers
    • 7.8.2 Market Limiters
  • 7.9 Competitive Market Share Analysis
    • 7.9.1 Dental Bone Graft Substitute Market Competitive Market Share Analysis
    • 7.9.2 Dental Barrier Membrane Market Competitive Market Share Analysis
    • 7.9.3 Antimicrobial Periodontal Treatment Market Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 7-1: Dental Bone Graft Substitute and Other Biomaterials by Segment, India, 2024
  • Chart 7-2: Dental Bone Graft Substitute and Other Biomaterials Market Overview, India, 2024 & 2031
  • Chart 7-3: Dental Bone Grafting Procedures by Segment, India, 2021 - 2031
  • Chart 7-4: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, India, 2021 - 2031
  • Chart 7-5: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, India, 2024

LIST OF FIGURES

  • Figure 7-1: Dental Bone Graft Substitute and Other Biomaterials Market Share Ranking by Segment, India, 2024
  • Figure 7-2: Factors Impacting the Dental Bone Graft Substitute and Other Biomaterials Market by Segment, India
  • Figure 7-3: Dental Bone Graft Substitute and Other Biomaterials Procedure Segmentation, India
  • Figure 7-4: Dental Bone Graft Substitute and Other Biomaterials Market Segmentation, India
  • Figure 7-5: Dental Bone Grafting Procedures and Penetration Rates by Segment, India, 2021 - 2031
  • Figure 7-6: Dental Bone Graft Procedure Numbers and Volume Usage by Application, India, 2021 - 2031 (1 of 2)
  • Figure 7-7: Dental Bone Graft Procedure Numbers and Volume Usage by Application, India, 2021 - 2031 (2 of 2)
  • Figure 7-8: Dental Bone Graft Units Sold by Procedure, India, 2021 - 2031
  • Figure 7-9: Resorbable Dental Barrier Membrane Units Sold by Size, India, 2021 - 2031
  • Figure 7-10: Non-Resorbable Dental Barrier Membrane Units Sold by Size, India, 2021 - 2031
  • Figure 7-11: Currency Exchange Rate, 2024
  • Figure 7-12: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, India, 2021 - 2031 (US$M)
  • Figure 7-13: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, India, 2021 - 2031 (IN₹M)
  • Figure 7-14: Total Dental Bone Graft Substitute Market, India, 2021 - 2031
  • Figure 7-15: Dental Bone Graft Substitute Market by Segment, India, 2021 - 2031 (US$M)
  • Figure 7-16: Dental Bone Graft Substitute Market by Segment, India, 2021 - 2031 (IN₹M)
  • Figure 7-17: Allograft Market by Material, India, 2021 - 2031 (US$M)
  • Figure 7-18: Allograft Market by Material, India, 2021 - 2031 (IN₹M)
  • Figure 7-19: Total Allograft Market, India, 2021 - 2031
  • Figure 7-20: Mineralized Allograft Market, India, 2021 - 2031
  • Figure 7-21: Demineralized Bone Matrix Allograft Market, India, 2021 - 2031
  • Figure 7-22: Xenograft Market, India, 2021 - 2031
  • Figure 7-23: Synthetic Market, India, 2021 - 2031
  • Figure 7-24: Total Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-25: Dental Barrier Membrane Market by Segment, India, 2021 - 2031 (US$M)
  • Figure 7-26: Dental Barrier Membrane Market by Segment, India, 2021 - 2031 (IN₹M)
  • Figure 7-27: Allograft Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-28: Xenograft Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-29: Bovine Xenograft Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-30: Porcine Xenograft Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-31: Synthetic Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-32: Dental Barrier Membrane Market by Material, India, 2021 - 2031 (US$M)
  • Figure 7-33: Dental Barrier Membrane Market by Material, India, 2021 - 2031 (IN₹M)
  • Figure 7-34: Resorbable Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-35: Non-Resorbable Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-36: Non-Reinforced Non-Resorbable Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-37: Titanium-Reinforced Non-Resorbable Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-38: Total Antimicrobial Periodontal Treatment Market, India, 2021 - 2031
  • Figure 7-39: Dental Wound Care Market by Type, India, 2021 - 2031 (US$M)
  • Figure 7-40: Dental Wound Care Market by Type, India, 2021 - 2031 (IN₹M)
  • Figure 7-41: Dental Soft Tissue Wound Care Market, India 2021 - 2031
  • Figure 7-42: Dental Wound Care Plugs Market, India, 2021 - 2031
  • Figure 7-43: Dental Wound Care Tape Market, India, 2021 - 2031
  • Figure 7-44: Dental Wound Care Foam Market, India, 2021 - 2031
  • Figure 7-45: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, India, 2024
  • Figure 7-46: Leading Competitors, Dental Bone Graft Substitute Market, India, 2024
  • Figure 7-47: Leading Competitors, Dental Barrier Membrane Market, India, 2024
  • Figure 7-48: Leading Competitors, Antimicrobial Periodontal Treatment Market, India, 2024